Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takumi Sato
Observed name:
T. Sato
Institutions:
Mount Sinai Hospital,
Icahn School of Medicine at Mount Sinai
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Mount Sinai Hospital,
University of Tokyo Hospital,
National Hospital Organization,
National Disaster Medical Center,
The University of Tokyo,
Icahn School of Medicine at Mount Sinai
show all 7
ORCID:
0009-0009-2290-2164
Observed ORCID:
0009-0009-2290-2164
OpenAlex ID:
A5102878448
The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis
2025
·
Kota Tokunaga
, Yu Fujiwara
, et al.
·
Targeted Oncology
·
18
PDF
Pancreatic ductal adenocarcinoma with a high expression of alcohol dehydrogenase 1B is associated with less aggressive features and a favorable prognosis.
2023
·
Kohei Chida
, Masanori Oshi
, et al.
·
PubMed Central
·
12
PDF
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment
2025
·
Brendan L. Hagerty
, Takumi Sato
, et al.
·
Annals of Surgical Oncology
·
11
Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression
2024
·
Kohei Chida
, Masanori Oshi
, et al.
·
Breast Cancer Research and Treatment
·
9
PDF
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer
2024
·
Takumi Sato
, Masanori Oshi
, et al.
·
Breast Cancer Research and Treatment
·
7
PDF
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
2026
·
Reo Omori
, Yu Fujiwara
, et al.
·
JNCI Cancer Spectrum
·
4
ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
2025
·
Takumi Sato
, Brendan L. Hagerty
, et al.
·
Annals of Surgical Oncology
·
1
Abstract 2039: High mesothelin expressing triple negative breast cancer is associated with enhanced cell proliferation but without impact on survival outcomes
2025
·
Takumi Sato
, Brendan Hagerty
, et al.
·
Cancer Research
·
1
ASO Visual Abstract: Mesothelin (MSLN) is Highly Expressed in Triple-Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Pro-inflammatory Tumor Microenvironment
2025
·
Brendan L. Hagerty
, Takumi Sato
, et al.
·
Annals of Surgical Oncology
·
1
Encouraging co-targeting of immunoregulatory molecules in cancer treatment
2025
·
Takumi Sato
, Yu Fujiwara
·
Immunotherapy
·
1
Abstract 2520: CD133 expression is associated with less DNA repair, better response to chemotherapy, and survival in ER-positive/ER-negative breast cancer
2024
·
Takumi Sato
, Masanori Oshi
, et al.
·
Cancer Research
·
1
Systemic complement C3 reduction in infertile women with endometrial dysbiosis: preliminary observations
2026
·
Shinya Yamaguchi
, Takumi Sato
, et al.
·
Reproduction Fertility and Development
PDF
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: A systematic review and meta-analysis.
2025
·
Reo Omori
, Yu Fujiwara
, et al.
·
Journal of Clinical Oncology
PDF
Endogenous mono-ADP-ribosylation in the hippocampus of amygdaloid kindled rat
1996
·
K. Suzuki
, H. Iwasa
, et al.
·
European Neuropsychopharmacology
Show more works
View as search
Works count:
14
Citation count:
66
H-index:
5
I10-index:
3
Year
Topic
Type